Genetic deletion of Bax (Bax-/-) prevents cell death in affected tissues in models of neurodegeneration, including Parkinson’s disease [8], Alzheimer’s disease [9], amyotrophic lateral sclerosis [10], and glaucomatous optic neuropathy (glaucoma) [1, 11]. Here, BAX is linked to early-onset autosomal dominant Alzheimer disease.